Rita Nocerino Selected Research

Milk Hypersensitivity (Milk Allergy)

7/2021	Tolerability of a new amino acid-based formula for children with IgE-mediated cow's milk allergy.
1/2021	The Impact of Formula Choice for the Management of Pediatric Cow's Milk Allergy on the Occurrence of Other Allergic Manifestations: The Atopic March Cohort Study.
1/2020	Tolerogenic Effect Elicited by Protein Fraction Derived From Different Formulas for Dietary Treatment of Cow's Milk Allergy in Human Cells.
10/2019	Dietary Treatment with Extensively Hydrolyzed Casein Formula Containing the Probiotic Lactobacillus rhamnosus GG Prevents the Occurrence of Functional Gastrointestinal Disorders in Children with Cow's Milk Allergy.
1/2018	Gut microbiota composition and butyrate production in children affected by non-IgE-mediated cow's milk allergy.
6/2017	Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow's milk allergy: 3-year randomized controlled trial.
1/2017	Extensively hydrolyzed casein formula alone or with L. rhamnosus GG reduces β-lactoglobulin sensitization in mice.
1/2017	Amino Acid-based Formula in Cow's Milk Allergy: Long-term Effects on Body Growth and Protein Metabolism.
8/2016	Antibody-independent identification of bovine milk-derived peptides in breast-milk.
3/2016	Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rita Nocerino Research Topics

Disease

16	Milk Hypersensitivity (Milk Allergy) 07/2021 - 12/2011
7	Food Hypersensitivity (Food Allergy) 01/2021 - 06/2013
3	Gastroenteritis 01/2021 - 05/2015
3	Dysbiosis 01/2019 - 06/2017
3	Hypersensitivity (Allergy) 01/2018 - 06/2013
2	Diarrhea 05/2015 - 02/2011
1	COVID-19 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Eczema 01/2021
1	Urticaria (Hives) 01/2021
1	Vomiting 01/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2018
1	Communicable Diseases (Infectious Diseases) 06/2017
1	Anaphylaxis (Anaphylactic Shock) 01/2017
1	Body Weight (Weight, Body) 09/2013

Drug/Important Bio-Agent (IBA)

10	Immunoglobulin E (IgE)IBA 07/2021 - 02/2013
8	Caseins (Casein)FDA Link 01/2021 - 01/2015
4	Amino Acids FDA Link 07/2021 - 02/2013
2	AntiemeticsIBA 01/2021 - 01/2021
2	Butyrates (Butyrate)IBA 01/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2017
2	Local Anti-Infective Agents (Antiseptics)IBA 01/2019 - 06/2017
2	CytokinesIBA 01/2016 - 01/2015
2	SolutionsIBA 05/2015 - 02/2011
2	ORALIT (ORS)IBA 05/2015 - 02/2011
2	ZincIBA 05/2015 - 02/2011
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	Serine (L-Serine)FDA Link 01/2021
1	Neuropilin-1IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	AntigensIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2018
1	Carnitine (L-Carnitine)FDA LinkGeneric 06/2018
1	EnzymesIBA 06/2018
1	Succinic Acid (Succinate)IBA 06/2018
1	Aconitate Hydratase (Aconitase)IBA 06/2018
1	AllergensIBA 01/2018
1	Volatile Fatty AcidsIBA 06/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	Interleukin-13IBA 01/2017
1	Interleukin-5 (Interleukin 5)IBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 06/2013
1	Lactoglobulins (beta-Lactoglobulin)FDA Link 12/2011
1	PrebioticsIBA 02/2011

Therapy/Procedure

2	Therapeutics 01/2016 - 05/2015
2	Fluid Therapy (Oral Rehydration Therapy) 05/2015 - 02/2011
1	Oral Administration 01/2021
1	Medical Day Care (Partial Hospitalization) 06/2017